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Vetsuisse-Fakultät Universität Zürich (2014) 
Sandra Schäfer 
Departement für Kleintiere, Klinik für Kleintiermedizin, msekey@vetclinics.uzh.ch 
Characterization of recombinant human and bovine thyroid-stimulating hormone preparations 
by mass spectrometry and determination of their endotoxin content 
 
The thyroid-stimulating hormone (TSH) stimulation test to confirm canine hypothyroidism is 
commonly performed using a recombinant human TSH (rhTSH), as up to date, canine TSH is 
not yet commercially available. Limiting factors for the use of rhTSH are its high costs and 
occasional difficulties in product availability. Less expensive bovine TSH preparations 
(bTSH) purified from bovine pituitary glands are readily commercially available. The aim of 
this study was to evaluate two different bTSH products as alternative to rhTSH using mass 
spectrometry. 
More than 50 proteins, including other pituitary hormones, bovine albumin, hemoglobin, and 
tissue proteins were identified in the bTSH preparations. In contrast, rhTSH proved to be a 
highly pure product. Significantly higher endotoxin levels could be detected in all bTSH 
products compared to the rhTSH. 
Both bTSH products are crude mixtures and therefore not an acceptable alternative to rhTSH. 
Their use should be discouraged to prevent unintended side effects. 
 
Keywords: Bovine TSH, Recombinant human TSH, Mass spectrometry, Endotoxin 
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Vetsuisse-Fakultät Universität Zürich (2014) 
Sandra Schäfer 
Departement für Kleintiere, Klinik für Kleintiermedizin, msekey@vetclinics.uzh.ch 
Characterization of recombinant human and bovine thyroid-stimulating hormone preparations 
by mass spectrometry and determination of their endotoxin content 
 
Zur Diagnosesicherung einer Hypothyreose beim Hund wird üblicherweise ein TSH-
Stimulationstest durchgeführt. Hierzu wird heute rekombinantes humanes TSH (rhTSH) 
verwendet, da bis dato kanines TSH kommerziell nicht erhältlich ist. Einschränkungen beim 
Gebrauch von rhTSH sind die hohen Kosten und gelegentliche Schwierigkeiten beim Erwerb 
für den veterinärmedizinischen Gebrauch. Bovine TSH (bTSH) Präparate, welche aus 
bovinen Hypophysen gewonnen und gereinigt werden, sind demgegenüber einfach und 
kostengünstig erhältlich. Das Ziel der vorliegenden Studie war die massenspektrometrische 
Untersuchung zweier verschiedener bTSH Produkte und der Vergleich mit rhTSH, um deren 
Einsatz als Alternative zum rhTSH zu prüfen. Ausserdem sollte bei allen drei Produkten 
mittels eines Limulus-Amöbozyten-Lysat Tests der Endotoxin-Gehalt untersucht werden. 
In beiden bTSH Präparaten konnten mehr als 50 verschiedene Proteine identifiziert werden, 
darunter andere hypophysäre Hormone, bovines Albumin, Hämoglobin und einige 
Gewebeproteine. Demgegenüber war das rhTSH ein hoch reines Produkt. Im Weiteren wurde 
in den bTSH Präparaten ein signifikant höherer Endotoxingehalt gemessen als im rhTSH. 
Unsere Untersuchungen belegen, dass beide bTSH Präparate unreine Stoffgemische und somit 
keine akzeptable Alternative zum rhTSH darstellen. Um ungewollte Nebenwirkungen zu 
vermeiden, muss von deren Verwendung abgeraten werden.  
 
Stichwörter: Bovines TSH, Rekombinantes humanes TSH, Massenspektrometrie, Endotoxin 
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Abstract 
Background 
The TSH stimulation test to confirm canine hypothyroidism is commonly performed using a 
recombinant human TSH (rhTSH), as up to date, canine TSH is not yet commercially 
available. Limiting factors for the use of rhTSH are its high costs and occasional difficulties 
in product availability. Less expensive bovine TSH preparations (bTSH) purified from bovine 
pituitary glands are readily commercially available. The aim of this study was to evaluate two 
different bTSH products as alternative to rhTSH using mass spectrometry. 
Results 
More than 50 proteins, including other pituitary hormones, bovine albumin, hemoglobin, and 
tissue proteins were identified in the bTSH preparations. In contrast, rhTSH proved to be a 
highly pure product. Significantly higher endotoxin levels could be detected in all bTSH 
products compared to the rhTSH. 
Conclusions 
Both bTSH products are crude mixtures and therefore not an acceptable alternative to rhTSH. 
Their use should be discouraged to prevent unintended side effects. 
Keywords 
Bovine TSH, Recombinant human TSH, Mass spectrometry, Endotoxin 
Background 
The TSH stimulation test has long been recognized as an accurate examination of thyroid 
function for the diagnosis of hypothyroidism in dogs. Increases in T4 (thyroxin) after the 
administration of exogenous TSH provide an assessment of the functional reserve capacity of 
the thyroid gland, and this helps discriminate true hypothyroidism from other conditions with 
low T4 secretion [1,2]. Canine TSH would be the ideal substance to perform the test, and 
although canine recombinant TSH could successfully be synthesized, it is not yet 
commercially available [3,4]. Therefore, the test is commonly performed using a recombinant 
human TSH (rhTSH) preparation [5-8]. Limiting factors, however, are the high cost of rhTSH 
and the occasional difficulties in obtaining the product. TSH purified from bovine pituitary 
glands (bTSH), which is easily commercially available, was widely used before rhTSH had 
been introduced in veterinary medicine. Equivalent biological activity of a bTSH product and 
the rhTSH has been shown in healthy beagle dogs [9]. However, in veterinary but also human 
medicine side effects after the use of bTSH were occasionally observed including allergic and 
anaphylactoid reactions [10-14]. Although they were assumed to result from impurities 
contained in the bTSH, a detailed characterization of commercially available bTSH to confirm 
this assumption has never been performed. 
Mass spectrometry (MS) has been used to monitor protein purifications and to identify 
components in protein or peptide mixtures [15-18]. MS has also been suggested as an 
excellent analytical tool to establish key differences between recombinant proteins and their 
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natural counterparts, especially when these products are intended for clinical use [17]. To our 
knowledge, no MS studies have been conducted to describe the composition of commercial 
bTSH products. 
Important contaminants found in parenteral drugs are endotoxins, also known as 
lipopolysaccharides (LPSs), components of the outer membrane of gram-negative bacteria. 
LPS in the blood circulation can lead to systemic inflammation and endotoxin shock [19]. 
Possible sources of endotoxins in drugs are chemicals, raw materials, or equipment used in 
the preparation and purification of the products. The Limulus Amebocyte Lysate (LAL) test is 
an officially accepted and very sensitive method to test endotoxin levels. To date, there are no 
published studies that compare the endotoxin content of different TSH preparations. 
Knowledge of the composition of bTSH and the identification of potentially dangerous 
contaminants, e.g., endotoxins in this product are both prerequisites for veterinary clinical use 
of bTSH. 
Therefore, aim of this study was to characterize commercially available purified bTSH (two 
different products) and rhTSH (one product) by MS. In addition, the levels of endotoxin were 
measured in both preparations by the Limulus endotoxin assay. 
Results 
Peptide and protein identification in bTSH 
bTSH and rhTSH samples were separated by SDS-PAGE before analyses by MS. Selected 
examples of Bis-Tris gels after electrophoresis and Coomassie Blue staining of bTSH and 
rhTSH-loaded gels are shown in Figure 1A (bTSH product 1, Sigma Aldrich) and 1B 
(rhTSH), respectively. 
Figure 1 Bis-Tris SDS PAGE gel of bTSH (product 1) and rhTSH (each 70 µg/lane); 
after electrophoretic separation, protein bands were detected by Coomassie Blue 
staining. The right lane of each gel represents the molecular weight marker (Prestained 
Protein Ladder; Page Ruler, Fermentas; Thermo Scientific, Glen Burnie, MD, USA), the left 
lane of gel A and B, the bTSH and rhTSH, respectively. 
In addition to bTSH, more than 50 other proteins were identified in all bTSH samples, 
including other pituitary hormones such as bovine prolactin, LH, arginine vasopressin (AVP), 
proopiomelanocortin (POMC), GH, oxytocin-neurophysin, and glycoprotein hormone alpha 
chain. Moreover, bovine albumin, hemoglobin, and cytoskeleton proteins were found in many 
of the tested samples. Interestingly, major differences in the composition of albumin were 
observed among the different lots of bTSH (bTSH product 1, Sigma Aldrich), while the 
pituitary hormones (prolactin, LH, AVP, glycoprotein hormone alpha chain, and TSH) were 
not significantly different between the lots. A list of selected proteins of both preparations is 
presented in Table 1 and 2, respectively. A complete summary of all identified proteins in 
bTSH product 1 (three different lots) and 2 (one lot) are presented as Additional file 1: Table 
S1 and Additional file 2: Table S2, respectively; accession number and number of assigned 
spectra are given. 
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Table 1 Selected proteins identified in the bTSH product 1 (Thyrotropic hormone from 
bovine pituitary, Sigma Aldrich; 3 lot numbers) by database search following mass 
spectrometry 
Identified(Proteins! LOT(069(K1588! LOT(119(K1583! LOT(040(M1246!
Prolactin! 143! 105! 60!
Lutropin!subunit!beta! 100! 84! 86!
Vasopressin;neurophysin2;copeptin! 85! 87! 61!
Thyrotropin!subunit!beta! 76! 64! 44!
Glycoprotein!hormones!alpha!chain! 57! 73! 75!
Pro;opiomelanocortin! 36! 35! 42!
Serum!albumin! 25! 1! 0!
Somatotropin! 12! 11! 8!
Beta;2;glycoprotein!1! 5! 2! 0!
Hemoglobin!subunit!beta! 4! 2! 3!
Oxytocin;neurophysin!1! 4! 2! 2!
Numbers!of!assigned!spectra!are!given! (corresponding! to! the!numbers!of! the!acquired!spectra!per!
protein).!
Table 2 Selected proteins identified in the bTSH product 2 (TSH, bovine pituitary, 
Calbiochem Merck; 1 lot number) by database search following mass spectrometry 
Identified(Proteins! LOT!
D00106386!
Beta;2;glycoprotein!1! 52!
Serum!albumin! 51!
Lactotransferrin! 45!
Hemoglobin!subunit!beta! 32!
Lutropin!subunit!beta! 16!
Glycoprotein!hormones!alpha!chain! 13!
Thyrotropin!subunit!beta! 13!
9!
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Vasopressin;neurophysin!2;copeptin! 7!
Somatotropin! 6!
Pro;opiomelanocortin! 4!
Hemoglobin!subunit!alpha! 3!
Follitropin!subunit!beta! 3!
Numbers!of!assigned!spectra!are!given! (corresponding! to! the!numbers!of! the!acquired!spectra!per!
protein).!
Peptide and protein identification in rhTSH 
In the rhTSH only TSH and several enzymes (e.g., caspase, galectin, serpin, calmodulin-like 
protein, and glyceraldehyde-3-phosphate dehydrogenase species) could be identified. In 
contrast to bTSH, the composition of rhTSH was extremely consistent between the different 
lot numbers. 
A list of selected proteins from the two lot numbers of rhTSH is shown in Table 3 and is 
given as the number of assigned spectra. A complete summary of all identified proteins in the 
rthTSH products is presented as Additional file 3: Table S3; accession number and number of 
assigned spectra are given. 
Table 3 Selected proteins identified in the rhTSH preparation (Thyrogen, Genzyme 
GmbH; 2 lot numbers) by database search following mass spectrometry 
Identified(Proteins! LOT! LOT!
A8035H40! A8063H19!
Thyrotropin!subunit!beta! 116! 126!
Glycoprotein!hormones!alpha!chain! 25! 26!
Numbers!of!assigned!spectra!are!given! (corresponding! to! the!numbers!of! the!acquired!spectra!per!
protein).!
Estimation of pituitary protein level 
The number of detectable peptides of the identified pituitary proteins was comparable. 
Therefore it was assumed that the number of the detected spectra reflected the individual 
abundances of the proteins, which allowed an estimation of the hormone quantities. Based on 
this assumption, the most commonly occurring proteins in the bTSH product 1 (Sigma 
Aldrich) were prolactin and LH and although not statistically significant there was a trend 
towards higher levels of both hormones compared to the TSH (p = 0.1) and a trend towards 
lower GH levels compared to those of TSH, LH and prolactin (Figure 2). The rhTSH 
preparation had only minor amounts of proteins other than TSH. 
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Figure 2 Numbers of assigned spectra of the hormones detected in the bTSH (product 1, 
Sigma Aldrich). Each symbol represents a lot number. The line represents the median of the 
3 different lot numbers of each hormone. Thyroid stimulating hormone (TSH), luteinizing 
hormone (LH), arginine vasopressin (AVP), proopiomelanocortin (POMC), growth hormone 
(GH). 
Contaminants such as keratin or trypsin, and proteins that were detected in bTSH and in 
rhTSH were eliminated from the analyses. 
Measurement of LH and GH by ELISA 
LH and GH were additionally measured by ELISA to confirm the findings of the MS with 
respect to the quantity of the hormone levels. The LH levels in the bTSH (product 1, Sigma 
Aldrich) samples were significantly higher compared to GH levels. Variations between the 
three different bTSH lots were only minimal and not statistically significant. Both, GH and 
LH levels in the rhTSH preparations were undetectable (Table 4). 
Table 4 Bovine luteinizing hormone (LH) and bovine growth hormone (GH) 
concentrations in bTSH and rhTSH preparations as determined by ELISA 
TSH(product! LOT! LH((μg/ml)! GH((μg/ml)!
bTSH! 040!M1246! 34.9! 2.59!
37.4! 2.29!
! 119!K1583! 35.4! 2.97!
34.5! 2.75!
rhTSH! A8063H19! <!1.2!ng/ml! <!0.8!ng/ml!
Endotoxin levels 
Results of the LAL kinetic chromogenic assays of bTSH and rhTSH preparations at different 
dilutions are presented in Table 5. Endotoxin levels of all bTSH preparations were 
significantly higher compared to rhTSH. Further, large variations in endotoxin levels were 
observed among the different lots of the bTSH product 1 (Sigma Aldrich). 
Table 5 Endotoxin concentrations in two bTSH products (Sigma Aldrich, 3 lot numbers; 
Calbiochem Merck 1 lot number) and rhTSH (2 lot numbers) as determined by Limulus 
amebocyte lysate (LAL) kinetic chromogenic assay 
Sample! LOT! Endotoxin/ml! Endotoxin/mg!
bTSH! 069!K1588! 434!EU/ml! 80.4!EU/mg!
(Sigma!Aldrich)! 119!K1583! 158.4!EU/ml! 29.3!EU/mg!
! 040!M1246! 133.6!EU/ml! 24.7!EU/mg!
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bTSH!
D00106386! 622!EU/ml! 12.4!EU/mg!
(Calbiochem!Merck)!
rhTSH! A8035H40! 0.15!EU/ml! 0.14!EU/mg!
(Genzyme!GmbH)! A8063H19! <0.05!EU/ml! <0.04!EU/mg!
Discussion 
Mass spectrometry analyses demonstrated that all bTSH samples of two different products 
contained in addition to TSH, more than 50 other proteins, including not only other pituitary 
hormones (e.g. LH, prolactin, AVP, POMC, and GH) but also bovine albumin, hemoglobin, 
and several tissue proteins (e.g., collagen, superoxide dismutase, and cathepsin). In contrast, 
in the rhTSH samples only TSH and a low number of enzymes used for its production were 
detected. 
Recombinantly produced proteins usually contain only the protein or peptide coded by the 
target gene, and some minor enzymes used in the commercial production process. rhTSH 
(Thyrogen) is produced in genetically engineered cell lines (Chinese hamster ovary cells- 
CHO) and is highly purified by a combination of ion exchange and dye affinity 
chromatography [20] (Genzyme Corporation, www.genzyme.com). 
In contrast to rhTSH, the bTSH products are purified proteins, prepared from the entire 
bovine pituitary gland. Depending on the purification procedure, it may be difficult to obtain a 
real pure product, particularly if proteins with high similarities to the target protein (in our 
case TSH) are present. It was therefore not surprising that other pituitary hormones were 
found in the various bTSH lots. Major cell types of the anterior pituitary are somatotropic 
cells, constituting approximately 50% of the cell population, followed by lactotropic (10-
25%), corticotropic (10-20%), gonadotropic (10%), and thyrotropic cells (10%) [21]. 
Based on the high proportion of somatotropic cells in a pituitary mixture, a higher quantity of 
growth hormone would be expected if the protein purification method was non-specific. 
However, the proportion of GH in bTSH as determined by MS analyses and ELISA was low, 
confirming that the TSH purification was to some extent specific. 
TSH belongs to the glycoprotein hormone family that includes FSH, hCG and LH; they are 
heterodimeric proteins and consist of a common α-subunit (or α-chain) and a unique β-
subunit, which confers biological specificity to each hormone. Due to the very high homology 
between TSH and LH, separation of the two hormones is difficult and necessitates extensive 
purification procedures [22-24], which in turn is laborious and expensive. Based on our 
results showing a rather high proportion of LH (demonstrated by MS and ELISA), it can be 
assumed that such a special purfication procedure has not been applied in the case of our 
bTSH. 
In a previous study, we found that the administration of 75 µg rhTSH to healthy beagle dogs 
resulted in stimulation of T4 similar to that caused by administration of 500 µg bTSH 
(product1) [9]. Based on the current results, the more than six times higher dose of bTSH 
required to elicit the same effect as rhTSH can be explained by the high content of 
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contaminating proteins in the bTSH lots. As mentioned above, the amounts of GH in the 
bTSH products were low, which led us to assume that at least some specific purification 
procedure was used; the more surprising was the finding of the highly variable amounts of 
bovine albumin that we could detect. Before rhTSH was available, bTSH given to human 
patients caused allergic reactions in up to 43% of the cases; some patients required emergency 
treatment [12-14]. Contaminating proteins such as albumin or globulins and antibodies 
against these proteins were suspected to be a likely cause and most side effects were observed 
after repeated injections of bTSH [12,13]. In veterinary medicine, side effects after the use of 
bTSH include allergic and anaphylactoid reactions [10,11]. Although these reactions were 
assumed to result from impurities contained in the bTSH, a detailed characterization to 
confirm this assumption has not been performed. If foreign albumin is administered, species 
differences in albumin can lead to anaphylactic and immunologic reactions. This has been 
shown both in human patients and in dogs [25-30]. Clinical symptoms in dogs receiving non-
canine albumin ranged from edema (facial, distal limbs), urticaria, vomiting, and diarrhea to 
severe shock-like reactions (hypotension, collapse). Some of these symptoms have also been 
observed in dogs receiving bTSH, making adverse reactions to albumin contained in bTSH a 
likely factor. In one veterinary study, reactions had only been observed after repeated 
administration of bTSH. The authors hypothesized that these reactions were the result of 
hypersensitization [11]. Clearly, to avoid hypersensitization, a canine TSH would be the most 
appropriate substance for performing the TSH stimulating test in dogs. However, to our 
knowledge, purified canine TSH is not commercially available in sufficient amounts and 
although recombinant canine TSH could successfully be synthesized, it is not yet on the 
market [3,4]. 
However, in one report, two fatal outcomes were described after a single administration of 
bTSH to dogs that had no prior exposure to bTSH [10]. A possible explanation in these cases, 
in which a hypersensitization can be excluded, would be the high endotoxin concentration in 
some bTSH lots. Based on the LAL assay, the endotoxin concentration in bTSH was up to 
500 times higher than that measured in rhTSH (434 and 0.27 EU/mL, respectively). 
Endotoxins in the blood circulation can lead to systemic inflammation and endotoxin shock 
with severe cardiovascular disturbances, multi-organ failure, and possible fatal outcome [19]. 
The highly variable endotoxin content in different lots makes adverse reactions unpredictable, 
and hence, the administration of bTSH to dogs is risky. Based on the high level of purity and 
the lack or minimal amount of endotoxin content, adverse reactions to rhTSH are unlikely. 
Therefore, compared to bTSH, rhTSH can be regarded as a much safer product. This 
assumption is supported by the finding that thus far, no adverse reactions in dogs have been 
observed even after the repeated administration of rhTSH [5,6,9]. In selected dogs in which 
hypothyroidism had been suspected, we repeated the TSH stimulation test three times using 
rhTSH. Even though the third test was performed within 12 to 24 months after the first 
stimulation, no dogs had adverse reactions after the rhTSH administration [6]. 
The bTSH is commonly used also for in vitro experiments to test the influence of TSH [31-
34]. With our data, we could show that other pituitary hormones, albumin, endotoxins and an 
extensive list of contaminating proteins (e.g., collagen, hemoglobin, superoxide dismutase, 
and cathepsin) are constituents in two different bTSH products. The effects of these impurities 
are rarely if ever considered in interpretations of the results from these cell culture 
experiments. However, in the light of our findings, the rhTSH should be preferred for in vitro 
usage if the sole effect of TSH has to be tested. 
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Conclusion 
The results of the present study show that rhTSH is a very pure product with minimal to no 
amounts of endotoxin, whereas bTSH is a crude mixture of proteins with a high level of 
endotoxin. Both, contaminating proteins like bovine albumin and the high endotoxin content 
in the bTSH can potentially lead to adverse reactions, which have been observed in the past, 
not only in humans, but also in veterinary medicine [10-14]. The highly variable and lot-
dependent composition of the bTSH makes adverse reactions unpredictable. Consequently, 
although less expensive and easily available, bTSH cannot be regarded as an alternative to the 
more expensive rhTSH, and its use should be discouraged to prevent unintended side effects 
in vitro and in vivo. 
Methods 
Sample preparation 
Two different bovine TSH products (Thyrotropic hormone from bovine pituitary; product 1 
Sigma Aldrich, Buchs, Switzerland and product 2 Calbiochem, Merck Chemicals, Lucerne, 
Switzerland) and rhTSH (Thyrogen, Genzyme GmbH, Baar, Switzerland) were analyzed. All 
TSH products were dissolved in aqua ad iniectabilia (Fresenius Kabi AG, Stans, Switzerland), 
and 70 µg total protein of each TSH sample were loaded separately onto a 12%- Bis-Tris gel 
(NuPage Novex Bis-Tris Mini Gel, Invitrogen AG, Basel, Switzerland). After separation, the 
gels were stained with colloidal Coomassie Blue (RotiBlue, Roth, Karlsruhe, Germany) and 
the stained gel lanes were excised, digested in-gel, and finally dissolved in 3% acetonitrile/ 
0.1% formic acid for MS analyses as previously described [35]. 
Mass spectrometry analyses 
Analyses were performed with an LTQ-FT-ICR Ultra mass spectrometer (Thermo Fisher 
Scientific, Pittsburgh, PA, USA) equipped with an Eksigent-Nano-high pressure liquid 
chromatography system (Eksigent Technologies, Dublin, CA, USA) as described by Moretti 
et al. [35]. An inclusion list was used containing the m/z values of all doubly and triply 
charged tryptic peptides from human (P01222) and bovine (P01223) TSH. 
Peptide and protein identification (data analyses) 
The MS data were analyzed and peptides identified with Mascot (Version 2.3.0, Matrix 
Science) using the Swiss-Prot database (release date, 05.Oct10; 521016 sequence entries). 
The peptide tolerance was set to ± 5 ppm, the MS/MS tolerance to ± 0.6 Da, and 
carbamidomethylation of cysteine was specified as a fixed modification. 
Determination of bovine growth hormone concentration 
The concentration of bovine growth hormone (GH) was measured in duplicate by an Enzyme-
linked Immunosorbant Assay (ELISA) using a GH antibody (10 mg/mL, 100 µL total volume, 
1: 200 000 dilution, anti-ovine GH-3, Lot# AFP0802210Rb) obtained from Dr. Parlow 
[National Hormone & Peptide Program (NHPP) of the National Institute of Diabetes and 
Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD, 
USA]. The assay was performed as previously described, but with the following 
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modifications [36,37]. The anti-ovine GH antibody was distributed into all wells of microtiter 
plates, which had been coated with anti-rabbit-globulin antiserum, and incubated for 24 h at 
room temperature. After decanting the supernatants, 15 µL of different concentrations of GH 
standard (0. 8–100 ng/mL, NIDDK-bGH, AFP-10325C) diluted in assay buffer (7.1 g/L 
Na2HPO4, 1.1 g/L KH2PO4, 1.2 g/L NaCl, and 1.8 g/L EDTA, pH 7.5; containing 1% chicken 
serum; 100 µg/well), and samples were added and incubated for 24 h. After incubation, the 
supernatants were discarded and biotin-labeled GH was added and incubated for 3 h at room 
temperature. Finally, the substrate was added (40 min at 37°C), and after stopping, the 
reaction, the optical density was measured at 450 nm. Only concentrations in the linear range 
of the standard curve were evaluated. Therefore, lower and upper detection limit for undiluted 
samples were 2.0 and 50.0 ng/mL, respectively (working range). The EIA method was 
validated for protein extraction samples by analyzing linearity of dilution and intra-assay 
coefficient of variation (CV) using the respective TSH diluted in GH assay buffer. The signal 
linearity of dilution was 81–96%, the intra-assay CV was 15.1%, and the 50% binding of this 
assay system was 6.2 ng/mL. Protein samples were diluted 1:10 in water and additionally 1:20 
in peptide buffer. 
Determination of bovine luteinizing hormone concentration 
Bovine luteinizing hormone (LH) concentration was measured in duplicate using a solid 
phase two-site enzyme immunoassay kit (LH Detect, INRA, Tours, France). The 
immunoassay was validated for purified protein samples by analyzing linearity of dilution, 
and the intra-assay CV. The assay sensitivity was 1 ng/mL, and the intra-assay CV was 9.6%. 
Linearity of dilution was 82–102%. Protein for LH detection was diluted in water at 1:100 
and additionally 1:100 in assay buffer. The standard curve ranged from 1.2 - 40 ng/mL. 
Endotoxin assay 
Endotoxin levels were measured using a Limulus amebocyte lysate (LAL) kinetic 
chromogenic assay (Pyrogent LAL Chromogenic Assay, Lonza, Verviers, Belgium). The test 
is based on the measurement of the chromophore released from a suitable chromogenic 
peptide by the reaction of endotoxins with the lysate. Bacterial endotoxin was measured with 
upper and lower detection limits of 0.05 and 50 Endotoxin units (EU)/mL, respectively. The 
sample was mixed with the LAL/substrate reagent, placed in an incubating plate reader, and 
monitored over time for the appearance of a yellow color, according to the instructions of the 
manufacturer. The same TSH lots were used for endotoxin assays and mass spectrometry. 
Results are given in both EU/mL and EU/mg. 
Statistical analyses 
Statistical support was provided by the biostatistical staff of the FGCZ. MS data were 
analyzed using Scaffold 3 (Proteome Software, Portland, OR, USA) The threshold for 
positive identification of a given protein was set to at least two peptides with a peptide 
probability of 95% or better. The minimal sequence coverage was set to a minimum of 10%. 
Data were further analyzed using non-parametric statistical methods (SPSS, Statistical 
Package for the Social Science, Software Packets for Windows, Version 18 and GraphPad 
PRISM® for Windows, Version 5.0.) Kruskal-Wallis, Wilcoxon and Dunn’s multiple 
comparisons test were used. The Mann–Whitney-U-Test was used to determine differences 
between two groups (hormones, endotoxins). Values of p < 0.05 were considered statistically 
significant. 
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Additional file 1  
Table 1 (complete, including accession number) 
Complete list of the proteins identified in the bTSH product 1 (Thyrotropic hormone 
from bovine pituitary, Sigma Aldrich; 3 lot numbers) by database search following 
mass spectrometry. Numbers of assigned spectra are given and the minimal 
sequence coverage was set to a minimum of 10%. Contaminations like keratin or 
trypsin, which were registered in bTSH as well as in rhTSH were excluded from 
analyses. 
 
Identified Proteins  Accession Number LOT 069K1588 LOT 119K1583 LOT 040M1246 
Prolactin sp|P01239| 143 105 60 
Lutropin subunit beta sp|P04651| 100 84 86 
Vasopressin-neurophysin 2-copeptin sp|P01180| 70 80 53 
Thyrotropin subunit beta sp|P01223| 70 54 44 
Glycoprotein hormones alpha chain sp|P01217| 57 73 75 
Cathepsin D sp|P80209| 46 38 48 
Pro-opiomelanocortin sp|P01190| 36 35 42 
Stathmin sp|Q3T0C7| 22 11 15 
Serum albumin sp|P49822| 17 0 0 
Macrophage migration inhibitory factor sp|P80177| 16 19 6 
Somatotropin sp|P01246| 12 11 8 
Proteasome activator complex subunit 1 sp|Q4U5R3| 10 5 3 
Prefoldin subunit 6 sp|Q17Q89| 9 0 6 
Glucosylceramidase sp|Q2KHZ8| 9 3 0 
Cystatin-C sp|P01035| 9 1 0 
Selenium-binding protein 1 sp|Q2KJ32| 8 18 1 
Vasopressin-neurophysin 2-copeptin sp|P01185| 8 6 5 
Cytochrome b-c1 complex subunit 7  sp|P00129| 8 4 3 
Cathepsin H sp|Q3T0I2| 8 2 3 
Serum albumin sp|P02769| 8 1 0 
Ubiquitin sp|P62990| 7 18 10 
Prefoldin subunit 1 sp|Q3SZE2| 7 4 6 
Ribonuclease UK114 sp|Q3T114| 7 4 4 
Vasopressin-neurophysin 2-copeptin (Fragment) sp|P01181| 7 1 3 
Protein S100-A11 sp|P24480| 7 3 2 
Cathepsin S  sp|P25326| 7 2 3 
Lysozyme C, non-stomach isozyme sp|P80189| 7 0 1 
Thyrotropin subunit beta sp|P01222| 6 10 0 
Epididymal secretory protein E1  sp|P79345| 6 3 3 
Fumarylacetoacetate hydrolase domain-containing 
protein 2 sp|Q2KIB0| 6 2 0 
Phosphatidylethanolamine-binding protein 1 sp|P13696| 5 35 9 
 2 
Connective tissue growth factor  sp|O18739| 5 1 5 
Thioredoxin sp|O97680| 5 1 0 
Beta-2-glycoprotein 1 sp|P17690| 5 2 0 
Palmitoyl-protein thioesterase 1  sp|P45478| 5 0 0 
Acidic mammalian chitinase sp|Q95M17| 5 0 0 
Superoxide dismutase [Cu-Zn] sp|P00442| 4 29 8 
ATP synthase-coupling factor 6, mitochondrial sp|P13618| 4 5 7 
Hemoglobin subunit beta sp|P02070| 4 2 3 
Oxytocin-neurophysin 1 sp|P01175| 4 2 2 
Cytochrome c oxidase subunit 5B, mitochondrial sp|P00428| 4 2 0 
Cytochrome c oxidase subunit 6B1 sp|P00429| 4 0 4 
Insulin-like growth factor-binding protein 6 sp|Q05718| 4 0 2 
Apolipoprotein A-I  sp|P02648| 4 0 0 
Chromogranin-A sp|P05059| 3 6 4 
Mitochondrial import inner membrane translocase 
subunit Tim9 sp|Q2KIV2| 3 6 5 
Proenkephalin-A sp|P01211| 3 7 3 
Coiled-coil domain-containing protein 58  sp|A4FUI1| 3 2 6 
Mitochondrial import inner membrane translocase 
subunit Tim10 sp|Q2NKR1| 3 3 2 
Beta-2-microglobulin  sp|P01888| 3 0 3 
Spleen trypsin inhibitor I  sp|P04815| 3 0 2 
Protein FAM136A  sp|Q2HJI3| 3 0 1 
Transthyretin sp|O46375| 3 0 0 
Insulin-like growth factor-binding protein 7 sp|Q16270| 2 2 5 
Glutathione peroxidase 1 sp|P00435| 2 0 7 
Cathelicidin-4 sp|P33046| 2 2 1 
Prefoldin subunit 5  sp|Q8HYI9| 2 2 1 
COX assembly mitochondrial protein homolog sp|Q3SZM6| 2 0 0 
TP53-regulated inhibitor of apoptosis 1 sp|O43715| 1 4 2 
Mitochondrial import inner membrane translocase 
subunit Tim13 sp|Q9Y5L4| 1 2 2 
Acylphosphatase-1 sp|P41500| 1 6 0 
Cytochrome c oxidase assembly protein COX19 sp|A8E4L1| 1 1 2 
Coiled-coil-helix domain-containing protein 3, 
mitochondrial sp|Q5E9D3| 0 2 3 
Acyl-CoA-binding protein sp|P07107| 0 2 0 
 
 
 1 
Additional file 2  
Table 2 (complete, including accession number)  
Complete list of identified proteins in the bTSH product 2 (TSH, bovine pituitary, 
Calbiochem Merck; 1 lot number) by database search following mass spectrometry. 
Numbers of assigned spectra are given and the minimal sequence coverage was set 
to a minimum of 10%. Contaminations like keratin or trypsin, which were registered in 
bTSH as well as in rhTSH were excluded from analyses.  
 
Identified Proteins Accession Number LOT D00106386 
Beta-2-glycoprotein 1 sp|P17690| 52 
Serum albumin sp|P02769| 51 
Lactotransferrin sp|P24627| 45 
Annexin A1 sp|P46193| 36 
Annexin A6 sp|P79134| 35 
Annexin A2 sp|A2SW69| 33 
Hemoglobin subunit beta sp|P02070| 32 
Filamin-A sp|P21333| 32 
Phospholipase D3 sp|Q2KJJ8| 29 
Stress-induced-phosphoprotein 1 sp|Q3ZBZ8| 25 
Peptidyl-prolyl cis-trans isomerase B sp|P80311| 25 
Annexin A3 sp|Q3SWX7| 25 
Eukaryotic translation initiation factor 5A-1 sp|P63241| 22 
Gelsolin sp|Q3SX14| 20 
Spectrin alpha chain, brain sp|P07751| 20 
Metalloproteinase inhibitor 2 sp|Q9TRZ7| 20 
Hepatoma-derived growth factor sp|Q9XSK7| 20 
Spectrin beta chain, brain sp|Q01082| 19 
Thrombospondin-1 sp|Q28178| 19 
Hemopexin sp|Q3SZV7| 17 
Prolargin sp|Q9GKN8| 17 
Lutropin subunit beta sp|P04651| 16 
Adenylate kinase 2, mitochondrial sp|P08166| 16 
Glycylpeptide N-tetradecanoyltransferase 1 sp|O70310| 14 
Interleukin enhancer-binding factor 3 sp|Q12906| 14 
Rho GDP-dissociation inhibitor 1 sp|P19803| 13 
Glycoprotein hormones alpha chain sp|P01217| 13 
Adenylyl cyclase-associated protein 1 sp|Q3SYV4| 13 
Calcyclin-binding protein sp|Q3T168| 13 
Thyrotropin subunit beta sp|P01223| 13 
GTP:AMP phosphotransferase, mitochondrial sp|P08760| 13 
Hepatoma-derived growth factor-related protein 3 sp|Q923W4| 13 
 2 
Vinculin sp|P18206| 12 
Transgelin sp|Q9TS87| 12 
Gamma-glutamyl hydrolase sp|A7YWG4| 11 
Neurofascin sp|O94856| 11 
Elongation factor 1-gamma sp|Q3SZV3| 11 
LDLR chaperone MESD sp|Q3T0U1| 11 
Glucosylceramidase sp|Q2KHZ8| 10 
Malate dehydrogenase, mitochondrial sp|Q32LG3| 10 
Peroxiredoxin-1 sp|Q5E947| 10 
Vesicle-associated membrane protein-associated protein A sp|Q0VCY1| 10 
Neuroblast differentiation-associated protein AHNAK sp|Q09666| 9 
SUMO-conjugating enzyme UBC9 sp|P63279| 9 
High mobility group protein B1 sp|A9RA84| 9 
Phosphatidylinositol-binding clathrin assembly protein sp|O55012| 9 
Phosphatidylethanolamine-binding protein 1 sp|P13696| 9 
Aminoacyl tRNA synthase complex-interacting multifunctional 
protein 1 sp|P31230| 9 
GDNF family receptor alpha-1 sp|P56159| 8 
Transcription elongation factor A protein 1 sp|Q29RL9| 8 
Microtubule-associated protein RP/EB family member 1 sp|Q3ZBD9| 8 
Peptidyl-glycine alpha-amidating monooxygenase sp|P10731| 8 
DNA-(apurinic or apyrimidinic site) lyase sp|P23196| 8 
Cathepsin L1 sp|P25975| 8 
Protein canopy homolog 3 sp|Q0P5N1| 8 
Serotransferrin sp|Q29443| 8 
Fermitin family homolog 2 sp|Q96AC1| 8 
Gamma-aminobutyric acid receptor-associated protein-like 2 sp|P60519| 8 
Ribosome-recycling factor, mitochondrial sp|Q0VCQ4| 8 
Cystatin-C sp|P01035| 7 
Methyl-CpG-binding protein 2 sp|P51608| 7 
Myosin light chain kinase, smooth muscle sp|Q28824| 7 
Vasopressin-neurophysin 2-copeptin sp|P01180| 7 
Insulin-like growth factor-binding protein 7 sp|Q16270| 7 
Tropomodulin-2  sp|Q9NZR1| 7 
Tetranectin sp|Q2KIS7| 7 
D-tyrosyl-tRNA(Tyr) deacylase 1 sp|Q2T9V8| 7 
BTB/POZ domain-containing protein KCTD12 sp|Q6WVG3| 7 
Nascent polypeptide-associated complex subunit alpha, muscle-
specific form sp|P70670| 6 
U2 small nuclear ribonucleoprotein A'  sp|P09661| 6 
Complement factor B  sp|P81187| 6 
Laminin subunit alpha-4 sp|Q16363| 6 
Cochlin sp|O43405| 6 
Thioredoxin sp|O97680| 6 
78 kDa glucose-regulated protein sp|P06761| 6 
 3 
Plasminogen sp|P06868| 6 
RNA-binding protein FUS  sp|P35637| 6 
Lumican sp|Q05443| 6 
Partner of Y14 and mago sp|A6QPH1| 6 
Somatotropin sp|P01246| 6 
Metalloproteinase inhibitor 1 sp|P20414| 6 
Factor XIIa inhibitor sp|P50448| 6 
Ribosome maturation protein SBDS sp|Q3SWZ6| 6 
Glucosamine 6-phosphate N-acetyltransferase sp|Q5RAL9| 6 
Peroxiredoxin-2 sp|Q9BGI3| 6 
Complement C3 sp|Q2UVX4| 5 
Microtubule-associated proteins 1A/1B light chain 3 beta 2 sp|A6NCE7| 5 
Sorbin and SH3 domain-containing protein 2 sp|O94875| 5 
Glutaminyl-tRNA synthetase sp|Q3MHH4| 5 
Alpha-enolase sp|Q9XSJ4| 5 
Non-muscle caldesmon sp|Q62736| 5 
Elongation factor 1-alpha 1  sp|A2Q0Z0| 5 
Microtubule-associated protein RP/EB family member 3 sp|Q5XIT1| 5 
Clathrin coat assembly protein AP180  sp|O60641| 5 
Heterogeneous nuclear ribonucleoprotein C sp|O77768| 5 
Heparin-binding growth factor 2 sp|P03969| 5 
Haptoglobin sp|Q2TBU0| 5 
Calcium-dependent secretion activator 1 sp|Q9ULU8| 5 
Eukaryotic translation initiation factor 3 subunit G  sp|O75821| 5 
Nucleolin sp|P19338| 5 
Protein disulfide-isomerase A3  sp|P38657| 5 
Ubiquitin carboxyl-terminal hydrolase 14 sp|P54578| 5 
Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 sp|Q17Q91| 5 
Protein NipSnap homolog 3A  sp|Q5RAA9| 5 
Protein dpy-30 homolog  sp|Q2NKU6| 5 
Leiomodin-1  sp|Q8BVA4| 5 
Spectrin beta chain, brain 1  sp|Q62261| 5 
Heat shock cognate 71 kDa protein  sp|A2Q0Z1| 4 
Protein AMBP sp|P00978| 4 
Lamina-associated polypeptide 2, isoform alpha sp|P42166| 4 
Transcription factor BTF3 sp|P20290| 4 
Collagen alpha-1(XIV) chain  sp|Q80X19| 4 
Pro-opiomelanocortin  sp|P01190| 4 
Proteasomal ubiquitin receptor ADRM1  sp|A1L5A6| 4 
Transcription activator BRG1 sp|A7Z019| 4 
Collagen alpha-1(II) chain sp|P02458| 4 
Glia-derived nexin sp|P07093| 4 
40S ribosomal protein S19  sp|P17074| 4 
60S ribosomal protein L12  sp|P23358| 4 
 4 
40S ribosomal protein S3  sp|P23396| 4 
Transgelin-2  sp|P37802| 4 
Mesencephalic astrocyte-derived neurotrophic factor sp|P80513| 4 
Nuclear migration protein nudC sp|Q17QG2| 4 
Lysosomal alpha-mannosidase  sp|Q29451| 4 
Complement C2  sp|Q3SYW2| 4 
Acyl-CoA-binding domain-containing protein 7 sp|Q3SZF0| 4 
Mitochondrial fission 1 protein  sp|Q3T0I5| 4 
Tetratricopeptide repeat protein 1  sp|Q3ZBR5| 4 
Ran-binding protein 3  sp|Q4R4T9| 4 
Protein DJ-1  sp|Q5E946| 4 
Talin-1  sp|Q9Y490| 4 
Vesicle-associated membrane protein-associated protein B  sp|A2VDZ9| 4 
Decorin  sp|P21793| 4 
Myotrophin  sp|P58546| 4 
Transcription factor BTF3 homolog 4  sp|Q2KIY7| 4 
Cysteine and glycine-rich protein 1  sp|Q3MHY1| 4 
Probable D-tyrosyl-tRNA(Tyr) deacylase 2  sp|Q96FN9| 4 
Dynein light chain 1, axonemal  sp|Q2KID4| 4 
DnaJ homolog subfamily A member 2 sp|O35824| 4 
Beta-2-glycoprotein 1  sp|P33703| 4 
Dynein light chain 2, cytoplasmic sp|Q3MHR3| 4 
40S ribosomal protein S3a sp|B0KW94| 3 
Ubiquitin-like protein 4A sp|B2KIK3| 3 
Synaptotagmin-1 sp|P21579| 3 
Sulfhydryl oxidase 1  sp|O00391| 3 
Pigment epithelium-derived factor  sp|Q95121| 3 
Prelamin-A/C  sp|P02545| 3 
Large proline-rich protein BAT3  sp|A5D9M6| 3 
Heterogeneous nuclear ribonucleoprotein Q  sp|O60506| 3 
Chromobox protein homolog 3 sp|Q13185| 3 
Protein S100-A13  sp|P79342| 3 
Collagen alpha-1(XVIII) chain  sp|P39061| 3 
Inter-alpha-trypsin inhibitor heavy chain H5  sp|A2VE29| 3 
Agrin  sp|O00468| 3 
Hemoglobin subunit alpha  sp|P01966| 3 
Cofilin-1  sp|P10668| 3 
Pleiotrophin  sp|P21782| 3 
Catenin alpha-1 sp|P26231| 3 
Annexin A11  sp|P27214| 3 
Cholinesterase sp|P32749| 3 
Antithrombin-III  sp|P41361| 3 
Arylsulfatase K  sp|Q148F3| 3 
Poly(rC)-binding protein 2  sp|Q15366| 3 
 5 
High mobility group protein B3  sp|Q32L31| 3 
PDZ and LIM domain protein 7  sp|Q3SX40| 3 
Leucine zipper transcription factor-like protein 1  sp|Q3ZBL4| 3 
Transcobalamin-2  sp|Q9XSC9| 3 
40S ribosomal protein S20  sp|A1XQU9| 3 
Follitropin subunit beta  sp|P04837| 3 
Thrombospondin-1  sp|P07996| 3 
Microtubule-associated protein 4  sp|P27546| 3 
Gamma-aminobutyric acid receptor-associated protein-like 1 sp|P60518| 3 
Retinoic acid receptor responder protein 2  sp|Q29RS5| 3 
PDZ and LIM domain protein 4  sp|Q3T005| 3 
Serine/arginine repetitive matrix protein 1  sp|Q5ZMJ9| 3 
Insulin-like growth factor-binding protein 7 sp|Q61581| 3 
Aspartyl-tRNA synthetase, cytoplasmic sp|Q3SYZ4| 2 
Heterochromatin protein 1-binding protein 3  sp|Q08DU9| 2 
Epsin-2  sp|O95208| 2 
Insulin-like growth factor-binding protein 3 sp|P20959| 2 
PC4 and SFRS1-interacting protein  sp|Q8MJG1| 2 
THO complex subunit 4  sp|B5FXN8| 2 
Vacuolar protein sorting-associated protein 4B  sp|O75351| 2 
Ubiquitin-conjugating enzyme E2-17 kDa  sp|P25867| 2 
Endoplasmic reticulum resident protein 29  sp|P30040| 2 
Activated RNA polymerase II transcriptional coactivator p15  sp|P53999| 2 
Tissue factor pathway inhibitor 2 sp|Q7YRQ8| 2 
Glycogen phosphorylase, liver form  sp|Q0VCM4| 2 
Protein S100-A10  sp|P04163| 2 
Cystatin-B sp|P25417| 2 
Small nuclear ribonucleoprotein Sm D3  sp|P62318| 2 
Ribosomal L1 domain-containing protein 1  sp|A4FV97| 2 
Transforming growth factor-beta-induced protein ig-h3 sp|O11780| 2 
NSFL1 cofactor p47  sp|O35987| 2 
PDZ and LIM domain protein 3  sp|O70209| 2 
Epsin-1  sp|O88339| 2 
Kinectin  sp|O97961| 2 
Histone H1.4 (Fragment)  sp|P02252| 2 
Collagen alpha-2(I) chain  sp|P02465| 2 
Fibronectin  sp|P02751| 2 
Sodium/potassium-transport. ATPase subunit beta-1  sp|P05028| 2 
Collagen alpha-3(VI) chain  sp|P12111| 2 
ATP synthase subunit O, mitochondrial  sp|P13621| 2 
Lamin-B1 sp|P14731| 2 
Oxysterol-binding protein 1  sp|P16258| 2 
Mimecan  sp|P19879| 2 
Secretogranin-1  sp|P23389| 2 
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Tenascin  sp|P24821| 2 
Peptidyl-prolyl cis-trans isomerase FKBP2 sp|P26885| 2 
Elongation factor 1-beta  sp|P34826| 2 
Protein S100-A4  sp|P35466| 2 
60S ribosomal protein L30  sp|P58372| 2 
DnaJ homolog subfamily B member 11  sp|P81999| 2 
Eukaryotic translation initiation factor 3 subunit J sp|Q0VCU8| 2 
Ubiquitin-conjugating enzyme E2 variant 1  sp|Q13404| 2 
ELAV-like protein 1  sp|Q15717| 2 
CB1 cannabinoid receptor-interacting protein 1 sp|Q17QM9| 2 
Heat shock 70 kDa protein 1B sp|Q27965| 2 
Collagen alpha-1(XII) chain (Fragment)  sp|Q28902| 2 
Suppressor of G2 allele of SKP1 homolog sp|Q2KIK0| 2 
Vitamin D-binding protein  sp|Q3MHN5| 2 
Hepatoma-derived growth factor-related protein 2  sp|Q3UMU9| 2 
PDZ and LIM domain protein 5  sp|Q96HC4| 2 
Cadherin EGF LAG seven-pass G-type receptor 2  sp|Q9HCU4| 2 
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Additional file 3  
Table 3 (complete, including accession number) 
Complete list of identified proteins in the rhTSH preparation (Thyrogen, Genzyme 
GmbH; 2 lot numbers) by database search following mass spectrometry. Numbers of 
assigned spectra are given and the minimal sequence coverage was set to a 
minimum of 10%. Contaminations like keratin or trypsin, which were detected in 
bTSH as well as in rhTSH were excluded from analyses.  
 
 Identified Proteins Accession Number 
LOT 
A8035H40 
LOT 
A8063H19 
Thyrotropin subunit beta sp|P01222| 116 126 
Glycoprotein hormones alpha chain sp|P01215| 25 26 
Glyceraldehyde-3-phosphate dehydrogenase sp|P04406| 6 1 
Calmodulin-like protein 5 sp|Q9NZT1| 5 1 
Caspase-14 sp|P31944| 4 1 
Serpin B12 sp|Q96P63| 5 0 
Galectin-7 sp|P47929| 2 0 
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